Indian infertility diagnosis and treatment market is anticipated to grow at a significant CAGR of 12.5% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. Several strategies by key players are
Browse the full report description of “Indian Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report, by Female Infertility Diagnosis (Ovulation Testing, Hysterosalpingography, Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others), by Male Infertility Diagnosis (Semen Analysis, Genetic Testing, Testicular Biopsy, Hormone Testing, and Others) and by Infertility Treatment (Drugs And Medicine, Surgical, Assisted Reproductive Technology (ART), and Others)Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/indian-infertility-market
• In December 2021, Delhi-based Crysta IVF introduced a new center in Mumbai. The center in Mumbai was launched in collaboration with Spring Fertility Centre. With the launch of this facility in the city, Crysta IVF strives to make fertility treatments accessible to everyone irrespective of the region or state.
• In August 2021, Indira IVF, has recently inaugurated two new centres at Uttar Pradesh’s Sultanpur and Bathinda in Punjab, reaching a milestone of establishing 100 centres across India. The major reason to establishing there branches in these areas is to take IVF treatment to the remotest parts of the country.
• In April 2021, Oasis Fertility launched a series of initiatives on the occasion of National Infertility Awareness Week 2021. The first of these initiatives is Ask Oasis Fertility, an entire resource that performs as a space for couples with infertility to connect with a fertility counselor and seek appropriate information and counseling regarding their issues. The second initiative is the We Can Conceive Facebook group which acts as a support group for people with infertility.
• In January 2021, Apollo Fertility announced its expansion into Northern India with the establishment of its first, state-of-the-art standalone fertility center in Noida. The standalone fertility and IVF center is equipped with a state-of-the-art CLASS 100 lab with separate AHU and HEPA filters, and laminar airflow embellished with advanced and modern technology.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Female Infertility Diagnosis
o By Male Infertility Diagnosis
o By Infertility Treatment
• Competitive Landscape- including Cipla Inc., GlaxoSmithKline plc., Abbott India Ltd., Cadila Healthcare Ltd, Crysta IVF, Dr. D Pharma, Maksun Biotech Pvt. Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Indian Infertility Diagnosis and TreatmentMarket Report Segment
By Female Infertility Diagnosis
By Male Infertility Diagnosis
By Infertility Treatment
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/indian-infertility-market